Volume 26, Issue 3 pp. 155-157
Full Access

Incidence of ABO haemolytic disease of the newborn in a group of Hong Kong babies with severe neonatal jaundice

C.-S. FENG

Corresponding Author

C.-S. FENG

Haematology Laboratory and Blood Bank, Prince of Wales Hospital, Hong Kong

Haematology Laboratory and Blood Bank, Prince of Wales Hospital, Shatin, NT, Hong Kong.Search for more papers by this author
C. P. WAN

C. P. WAN

Haematology Laboratory and Blood Bank, Prince of Wales Hospital, Hong Kong

Search for more papers by this author
J. LAU

J. LAU

Centre for Clinical Trials and Epidemiological Research, Hong Kong

Search for more papers by this author
T.-K. LAM

T.-K. LAM

Department of Paediatrics, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Search for more papers by this author
T.-F. FOK

T.-F. FOK

Department of Paediatrics, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Search for more papers by this author
First published: June 1990
Citations: 5

C. S. Feng MB, BS, FRCPA, Director; C. P. Wan, AIMLT, Medical Technologist; J. Lau, BS, Computer Officer; T-K. Lam, MB, BS, MRCP, Lecturer; T-F. Fok, MB, BS, MRCP, Senior Lecturer.

Abstract

Abstract Two methods were used to determine the incidence of ABO haemolytic disease of the newborn (ABO-HDN) among Hong Kong Chinese infants. The first method employed the Lui elution technique to elute anti-A, B from cord blood of Group A and B babies with a Group O mother, and set out to correlate the titration score of the eluate with the serum bilirubin of the neonates. This method proved to be a failure because of the poor correlation. The second method was mathematical. By comparing the ‘expected’ frequency of various mother-infant ABO combinations (based on the ABO distribution of our local population) with the ‘observed’ frequency of a cohort of infants with severe neonatal jaundice, it was found that only two combinations (O-A and O-B mother-infant pairs) were responsible for ABO-HDN, for which the incidence was 1 in 5 among infants with a serum bilirubin level of 300 μmol/L or more.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.